NORMA VELA: Open Payments
NPI 1568129153 · KINGSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 93 payments from 7 companies in 2025. Trend: 2023 $2,155 · 2024 $2,272 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $372 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $366 |
| Neurocrine BioSciences, Inc. | 14 | $357 |
| E.R. Squibb & Sons, L.L.C. | 18 | $244 |
| Alkermes, Inc. | 10 | $214 |
| Supernus Pharmaceuticals, Inc. | 12 | $164 |
| ABBVIE INC. | 1 | $19 |
Products named: CAPLYTA, INGREZZA, UZEDY, COBENFY, Qelbree, LYBALVI, AUSTEDO XR, ARISTADA.
Industry payments across TX — which companies pay providers there.
